Patricia Aspichueta Celaa-rekin lankidetzan egindako argitalpenak (4)

2024

  1. Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)

    Hepatology, Vol. 79, Núm. 1, pp. 135-148

2017

  1. Deregulated neddylation in liver fibrosis

    Hepatology, Vol. 65, Núm. 2, pp. 694-709

  2. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis

    Gastroenterology, Vol. 152, Núm. 6, pp. 1449-1461.e7

2013

  1. Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease

    Hepatology, Vol. 57, Núm. 2, pp. 505-514